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Abstract
Background: Little is known about the genes involved in the initial cyst formation and disease
progression in autosomal dominant polycystic kidney disease (ADPKD); however, such knowledge
is necessary to explore therapeutic avenues for this common inherited kidney disease.
Findings:  To uncover the genetic determinants and molecular mechanisms of ADPKD, we
analyzed 4-point time-series DNA microarrays from Pkd1L3/L3 mice to generate high resolution
gene expression profiles at different stages of disease progression. We found different
characteristic gene expression signatures in the kidneys of Pkd1L3/L3 mice compared to age-matched
controls during the initial phase of the disease. By postnatal week 1, the Pkd1L3/L3 kidney already had
a distinctive gene expression pattern different from the corresponding normal controls.
Conclusion: The genes differentially expressed, either induced or repressed, in ADPKD are
important in immune defense, cell structure and motility, cellular proliferation, apoptosis and
metabolic processes, and include members of three pathways (Wnt, Notch, and BMP) involved in
morphogenetic signaling. Further analysis of the gene expression profiles from the early stage of
cystogenesis to end stage disease identified a possible gene network involved in the pathogenesis
of ADPKD.
Findings
ADPKD is one of the most common lethal genetic dis-
eases in the world, with a prevalence of about one in every
400 to 1000 persons and a 50% chance that an ADPKD
patient will die of kidney failure [1-3]. Early changes in
the disease process are very important, and unraveling
more of the initial steps in pathogenesis may afford
patients better management possibilities and an
improved prognosis. Determining the molecular mecha-
nism of the pathogenesis of ADPKD, including the early
period of cyst formation, requires investigation of changes
from before the earliest period of disease manifestation in
a defined animal model that mimics the human disease
[4-6]. One well-used approach to unravel the molecular
pathogenesis and pharmacology of metabolic and genetic
diseases is the cDNA microarray [7-9]. We have previously
developed an animal model of ADPKD by generating
Pkd1L3/L3 mutant mice [10]. Homozygous Pkd1 null mice
appear normal when born, but rapidly develop polycystic
kidneys and generally do not live longer than 3.5 to 4
weeks. Here we refined the genetic background of our
Pkd1L3/L3 mutant mice so that the disease more closely
resembles most human ADPKD individuals in the late
onset of symptoms and final progression to end-stage
Published: 21 December 2008
BMC Research Notes 2008, 1:131 doi:10.1186/1756-0500-1-131
Received: 18 September 2008
Accepted: 21 December 2008
This article is available from: http://www.biomedcentral.com/1756-0500/1/131
© 2008 Li et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Research Notes 2008, 1:131 http://www.biomedcentral.com/1756-0500/1/131
Page 2 of 10
(page number not for citation purposes)
renal disease (ESRD). This refined animal model will
facilitate the study of ADPKD progression and the evalua-
tion of possible treatments. In this paper we present the
gene expression profile of Pkd1L3/L3 mice and their normal
littermates at different time points, as determined by
cDNA microarray. The materials and methods used in this
study were described detail in the additional file 1.
Results
Characterization of Pkd1L3/L3 Mice on a Congenic C57BL/
6 Background
During the course of refinement of the genetic back-
ground of the ADPKD model mice to a congenic C57BL/
6 genetic background, an earlier onset of polycystic kidney
phenotype (see Additional file 2) was seen than with the
previous mice on the SV129/C57BL6 background. Histo-
logical examination revealed that the translucent enlarged
kidneys were due to the formation of numerous large cysts
in homozygous mutant mice. Smaller cysts formed early
in PNW 1, and became larger at PNW 2. The cysts were
disseminated and distributed cross the cortex and
medulla. At PNW 3.5, the cyst occupied the entire kidney
and normal kidney architecture was hardly seen (see
Additional file 2C). All Pkd1L3/L3 mice were born nor-
mally, but most of them did not survive past four weeks
(see Additional file 3A) in the congenic C57BL/6 back-
ground. In gross appearance, there was no difference
between Pkd1L3/L3 mice and their age-matched control lit-
termates at PNW 1, but Pkd1L3/L3 mice were shorter of stat-
ure with a slightly wider abdomen by PNW 2, and more
obviously so by PNW 3 (see Additional file 2A). On
necropsy, these homozygous mutant mice had much
enlarged and translucent kidneys compared to their heter-
ozygous or wild-type littermates (see Additional file 2B).
The gross kidney alterations were first seen at PNW 2 and
became more severe at later time points. Although the
body weight was only moderately reduced in
homozygous mutants (see Additional file 3B), there was a
large increase in kidney weight/body weight ratio (kw/
bw) (see Additional file 3C) and kidney volume (see
Additional file 3D) in homozygous mutant mice. Similar
changes in kidney volume were seen in Pkd1L3/L3 mice
compared to the control littermates. Renal function was
also severely impaired in homozygous mutant mice as
evidenced in the progressive rise in BUN (see Additional
file 3E).
Overview of Temporal Expression Profile of Pkd1L3/L3 
Kidney
To study the detailed gene expression profile of ADPKD,
we generated and compared gene expression profiles of
Pkd1L3/L3 mice and their aged-matched wild-type litterma-
tes at different stages, i.e. PNW 1, 2, 3 and 3.5.
There were significant differences in expression profile
seen at all timepoints examined (Figure 1A). 4,231 genes
were found to be differentially expressed in the Pkd1L3/L3
kidney at one or more timepoint (Figure 1B and see Addi-
tional file 4), and these genes were assigned to one of 16
functional categories (Figure 1C) based on a previous clas-
sification. The number of genes in each functional class
that differed at each time point of the disease was then
determined (see Additional file 5) and the top 10 genes in
each group according to their gene expression ratio at
PNW 3.5 were listed (see Additional file 6).
Validation of Genes Involved in the Wnt, Notch, and BMP 
Signaling Pathway
In addition, several genes differentially expressed in this
model are components of three morphogenetic signaling
pathways. Quantitative real time PCR was performed to
validate gene expression changes identified by microarray
analysis during disease progression (see Additional file 7
for details of primers and conditions). Genes involved in
the Wnt, Notch and BMP signaling pathway were exam-
ined, and most gene expression patterns were consistent
with the microarray results (Figure 2A).
Transcriptome Alteration in Pkd1L3/L3 Kidney in the Early 
Phase of ADPKD
An original goal of this study was to identify gene expres-
sion alterations in Pkd1L3/L3 kidney during the initial and
progressive phases, which may represent specific land-
marks in a molecular signature of ADPKD. A total of 50
genes met these criteria by PNW 1 (see Additional file 8):
16 upregulated genes and 34 downregulated genes. The
genes affected were virtually all implicated in adaptive
and/or pathogenic mechanisms that might be linked to
cystogenesis or disease progression (see Additional file 8).
To further confirm the differential gene expression at
PNW1 observed with the PKD custom microarray and
suggested by IPA as being important, we validated the dif-
ferential expression of the Klk gene family using quantita-
tive real-time PCR analysis normalized against the
housekeeping gene Gapdh. The genes selected were Klk3,
Klk1b5, Klk1b8, Klk1b26, Klk1 and Klk1b9. The expression
pattern of all selected genes was consistent with the micro-
array results (Figure 2B). In general, PCR-based estimates
of expression change were larger than those observed in
the microarray study. These genes may prove useful as
potential therapeutic target candidates.
Pathway Analysis of Differentially Expressed Genes in 
Pkd1L3/L3 Mice at Initial and Progressive Phase
To gain insight into the potential functional consequences
of differentially expressed genes in Pkd1L3/L3 mice, the dif-
ferentially expressed genes were analyzed by the program
IPA (Table 1). IPA identified 4 significant networks
among the early genes altered in the Pkd1L3/L3 mice atBMC Research Notes 2008, 1:131 http://www.biomedcentral.com/1756-0500/1/131
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Relative gene expression levels in Pkd1L3/L3 kidney compared to control Figure 1
Relative gene expression levels in Pkd1L3/L3 kidney compared to control. (A) Hierarchical clustering of Pkd1L3/L3/wild-
type expression ratios for 4,231 genes differentially expressed in kidney at one or more ages between PNW 1 and PNW 3.5 
(replicate samples normalized to wild-type at each age). Genes more highly expressed in Pkd1L3/L3 mice are indicated in red; 
those expressed in Pkd1L3/L3 mice at levels lower than wild-type mice are indicated in green. Red and green represent up- and 
downregulation, respectively (see scale in lower right corner). Ten gene clusters were identified as labeled at right. Vertical 
black bars on the sides (1,917 downregulated genes in A1–A5, and 1,806 upregulated genes in A6–A10) indicate regions with 
characteristic gene expression change patterns. (B) Numbers of differentially regulated genes by age in Pkd1L3/L3 mice. (C) Func-
tional class proportions of all genes differentially expressed in Pkd1L3/L3 and wild-type mice from all time points (PNW 1, 2, 3 
and 3.5).
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Validation of genes involved in the Wnt, Notch and BMP signaling pathways and early differentially expressed genes at PNW 1 Figure 2
Validation of genes involved in the Wnt, Notch and BMP signaling pathways and early differentially expressed 
genes at PNW 1. (A) Twenty differentially expressed genes from the microarray were validated by RT-PCR using Gapdh as a 
reference gene. The time point that showed the greatest relative change in the microarray was selected for RT-PCR. (B) RNA 
was extracted from Pkd1L3/L3 mice and age-matched control littermates at PNW 1. The RT-PCR and microarray results are 
compared in the same figure (mean ± SD of triplicate PCR reactions of pooled RNA; n = 3; *, P < 0.05; **, P < 0.01 compared 
with wild-type mice, by Student's t-test).
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PNW 1, associated with cardiovascular system develop-
ment and function, gene expression, and cell morphology
(Table 1). We also analyzed PNW 2, 3 and 3.5 data with
IPA (see Additional file 9), and we found other network
might be involved in the pathogenesis of ADPKD during
disease progression, such as tissue morphology, develop-
ment, and cellular movement.
Correlation Analysis Identifies Genes Progressively Induced 
or Repressed with Disease
In order to find genes related to disease progression, the
Pearsons' correlation coefficient of affected genes of
Pkd1L3/L3 mice at PNW 1, 2, 3 and 3.5 was calculated. A
small number of genes whose expression was constant in
control mice but whose expression either continuously
increased or decreased in Pkd1L3/L3 mice was identified,
and the 5 annotated genes most well correlated to disease
progression (with P values lower than 0.05) are shown in
Table 2 and Figure 3A–E. RT-PCR was performed to vali-
date these five genes. The expression of these genes
increased progressively, consistent with the microarray
results (Figure 3F–J).
IHC Staining of Transforming Growth Factor Receptor 
(Tgfβr) 1 and 2 Expression
We also performed immunostaining to investigate TGF-
beta receptor expression in kidney at corresponding time
points. In PNW 3.5 wild-type mice, there was only faint
staining for TGFβ Receptor 1, mainly in renal tubules. In
Pkd1L3/L3 kidney, TGFβ Receptor 1 was strongly expressed
in cyst epithelium and interstitium (Figure 4A). The over-
expression pattern was also seen with TGFβ Receptor 2.
Significantly increased TGFβ Receptor 2 immunostaining
was observed in Pkd1L3/L3 kidney in cyst epithelium, inter-
stitium and distorted glomeruli, in contrast to the weak
staining in wild-type littermates (Figure 4B).
Confirmation of PKD Custom Microarray Findings 
Through Quantitative Real-Time PCR Analyses
To further confirm the differential gene expression at each
time point observed with the PKD custom microarray, we
validated their differential expression patterns using real
time PCR analysis. We randomly selected six up-regulated
genes, Zfp711, Lox, Npal1, Spata6, Ptrf and Tgfβr (Figure
5A–F), and four down-regulated genes, F13b, Vstm2,
Slc2a2  and  Tnfaip8  (Figure 5G–J), and verified their
expression level by quantitative real time PCR, normal-
ized against the housekeeping gene Gapdh. The expression
pattern of all selected genes was similar to and consistent
with the microarray results (Figure 5A–J). In general, PCR-
based estimates of expression change were larger than
those observed in the microarray study. These genes may
prove useful as potential therapeutic target candidates.
Conclusion
Comprehensive gene expression profiles from early to end
stage ADPKD were generated from Pkd1L3/L3  mice, an
improved disease model. Several distinct early expression
signatures of differentially expressed genes with potential
roles in cystogenesis were identified. These genes are
involved in several pathways including cell proliferation,
apoptosis, transport, and immune defenses. A variety of
biochemical pathways are clearly involved in the patho-
genesis of ADPKD, both in initial cystogenesis and
throughout disease progression, with extensive crosstalk
between different pathways. Further investigation of these
genes and their associated networks may provide insight
into the possible pathogenic mechanisms of ADPKD
development, and identify potential diagnostic and prog-
nostic markers and novel therapeutic targets.
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Table 1: Networks generated from IPA for differentially expressed genes in the Pkd1L3/L3 mice at PNW 1a
Network ID Genes in network Score # of Focus Genes Top categories
1 ↓ABCG2, ↑ALDH1A1, ↓CTSL2, 
↓F13B, ↓GATM, ↓IDH1, ↑IL17RB, 
↓KLK3, ↓KLK1 (includes EG:16612), 
↓KLK1, ↓KLK1B9, ↓KLK1B26, ↓PAH, 
↑VWF
36 14 Cardiovascular System Development and Function, Gene 
Expression, Cell Morphology
2 ↓ACSS1, ↓EGFR, ↑ KRT18, ↓SLC2A2 7 4 Gene Expression, Cell Cycle, Cell Death
3 ↑GLDN 3 1 Cellular Movement, Nervous System Development and 
Function, Cancer
4 ↑AADAC 3 1 Carbohydrate Metabolism, Cancer, Hepatic System 
Disease
aGenes whose expression was either increased or decreased in Pkd1L3/L3 mice as a function of age were identified by correlation analysis across four 
time points: 1,2, 3 and 3.5 weeks.BMC Research Notes 2008, 1:131 http://www.biomedcentral.com/1756-0500/1/131
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Selected genes which might be related to disease progression from correlation analysis and RT-PCR validation Figure 3
Selected genes which might be related to disease progression from correlation analysis and RT-PCR valida-
tion. Genes whose expression increased or decreased with disease progression were identified by correlation analysis of 
microarray data (A~E). Changes in transcript abundance are expressed as amount of change relative to control mean for that 
gene, and individual values of three different mice and the mean are shown at each week. (F~J) Validation of the microarray 
results by QRT-PCR analysis, showing relative change of PCR signal between wild-type and Pkd1L3/L3 mice (mean ± SD of tripli-
cate PCR reactions of pooled RNA; n = 3; *, P < 0.05; **, P < 0.01 compared with wild-type mice, by Student's t-test).
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Table 2: Top-scoring genes from correlation analysisa
Gene symbol Description Correlation P-value
Cxcl14 Chemokine ligand 14 0.999 1.14E-03
Edn1 Endothelin 1 0.998 2.25E-03
Arhgap30 Rho GTPase activating protein 30 0.992 7.85E-03
Prkab1 Protein kinase AMP-activated beta 1 non-catalytic subunit 0.990 9.61E-03
Tgfbr2 Transforming growth factor, beta receptor II 0.959 4.07E-02
aGenes whose expression was either increased or decreased in Pkd1L3/L3 mice as a function of age were identified by correlation analysis across four 
time points: 1,2, 3 and 3.5 weeks.
Elevated expression of TGFβR1 and TGFβR2 in Pkd1L3/L3 and control mice at PNW 3.5 Figure 4
Elevated expression of TGFβR1 and TGFβR2 in Pkd1L3/L3 and control mice at PNW 3.5. Immunohistochemistry of 
kidney of Pkd1L3/L3 and control mice at PNW 3.5, using monoclonal antibody to TGF-β receptor subtypes 1 and 2, visualized 
with diaminobenzidine (DAB). Representative images for Tgfbr1 (A) and Tgfbr2 (B) are shown. Scale bar shows 100 μm.
Wt Pkd1L3/L3
20x 20x
Tgfbr1
20x 20x
Tgfbr2
Wt Pkd1L3/L3
A
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RT-PCR analyses of selected genes (Zfp711, Lox, Npal1, Spata6, Ptrf, Tgfbr1, F13b, Vstm2, Slc2a2 and Tnfaip8) of Pkd1L3/L3 and  control mice at different stages Figure 5
RT-PCR analyses of selected genes (Zfp711, Lox, Npal1, Spata6, Ptrf, Tgfbr1, F13b, Vstm2, Slc2a2 and Tnfaip8) of 
Pkd1L3/L3 and control mice at different stages. RNA was extracted from Pkd1L3/L3 mice and age-matched control litterma-
tes at PNW 1, 2, 3 and 3.5. Three micrograms of total RNA from each group were reverse transcribed and cDNA equivalent 
to 10 ng total RNA was used for the PCR reactions. The graphs represent the relative change compared to control groups 
after normalization against Gapdh expression (mean ± SD of triplicate PCR reactions of pooled RNA; n = 3; *, P < 0.05; **, P < 
0.01 compared with wild-type mice, by Student's t-test).
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Additional material
Additional file 1
Materials and methods. The animal experiment, microarray, data anal-
ysis and Real-Time PCR were described detail in this file.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S1.doc]
Additional file 2
Postnatal growth retardation, kidney enlargement and progression of 
renal cystic lesions in Pkd1L3/L3 mutant mice. (A) Gross appearance of 
Pkd1L3/L3 mutant mice and their normal littermates at postnatal weeks 
(PNW) 1, 2, 3, and 3.5. Note the progressive abdominal enlargement in 
Pkd1L3/L3 mutant mice. (B) Kidney morphology of Pkd1L3/L3 mutant 
mice and normal littermates at PNW 1, 2, 3, and 3.5. The enlarged pale 
and semi-translucent kidney in Pkd1L3/L3 mutant mice was first seen at 
PNW 2 and became more evident at later time points. (C) H&E-stained 
kidney sections at PNW 1, 2, 3, and 3.5. Numerous cysts formed and pro-
gressively enlarged in kidney parenchyma in both cortex and medulla. 
(Scale bar = 2000 μm) All images (A-C) are representative of findings in 
at least three mice per genotype in two independent experiments.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S2.ppt]
Additional file 3
Early mortality, kidney enlargement, and loss of renal function in 
Pkd1L3/L3 mutant mice. Most mutant mice died before 28 days of age. 
Data from both males and females has been pooled. (A) Survival curves 
of wild-type (filled circle; n = 15), Pkd1L3/+ (open circle; n = 15), and 
Pkd1L3/L3 (filled triangle; n = 15) mice. Most mutant mice died before 28 
days of age. Data from both males and females has been pooled. Body 
weight (B), ratio of kidney weight to body weight (%BW; C) and kidney 
volume (D) of wild-type, Pkd1L3/+, and Pkd1L3/L3 mutant mice were 
recorded at PNW 1, 2, 3, and 3.5. (E) Deterioration in renal function in 
Pkd1L3/L3 mutant mice. Mice were sacrificed and sera collected at PNW 
1, 2, 3, and 3.5. BUN was determined from plasma concentration; n = 6 
at each genotype and age; *, P < 0.05.; **, P < 0.01 compared with wild-
type or heterozygous mice, by Student's t-test).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S3.ppt]
Additional file 4
Completed gene list of all transcripts significantly changed between 
wild-type and Pkd1L3/L3 mice at one or more time points. A table show-
ing all transcripts identified as changing significantly between wild-type 
and Pkd1L3/L3 mice (Raw: intensity of Pkd1L3/L3 mice; Control: intensity 
of wild-type; t-test, P < 0.05; relative increase > 1.5 or < 1/1.5), and 
ranked by the ratio at PNW3.5. We also listed the functional group and 
clustering number in this table including relative change at each time 
point, accession number, gene symbol and the number of functional group 
and cluster group.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S4.xls]
Additional file 5
Functional classification of genes differentially expressed between 
Pkd1L3/L3 mice and age-matched control littermates. Numbers of genes 
differentially expressed between Pkd1L3/L3 mice and age-matched control 
littermates at each time point, grouped by functional categories.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S5.ppt]
Additional file 6
List of top 10 genes differentially expressed at each functional group. 
The 10 genes with the largest changes in expression in wild-type and 
Pkd1L3/L3 mice in each functional group, including relative change at 
each timepoint, accession number and gene symbol (Raw: intensity of 
Pkd1L3/L3 mice; Control: intensity of wild-type).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S6.xls]
Additional file 7
Primers and experimental conditions of Gapdh and validated genes 
confirmed with real-time RT-PCR. This table contains a complete list 
and details of amplification conditions for the primers used in the RT-PCR 
analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S7.doc]
Additional file 8
Differentially expressed genes in the kidney of Pkd1L3/L3 mice and age-
matched control littermates at PNW 1of ADPKD. List of genes that 
were differentially expressed in wild-type and Pkd1L3/L3 mice at PNW 1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
0500-1-131-S8.doc]
Additional file 9
Top 5 networks generated from IPA at PNW 2, 3 and 3.5. List of Inge-
nuity networks generated by the focus genes that were differentially 
expressed in wild-type and Pkd1L3/L3 mice at PNW 2, 3 and 3.5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1756-
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